These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 25188501

  • 21. Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia.
    Naber D, Hansen K, Forray C, Baker RA, Sapin C, Beillat M, Peters-Strickland T, Nylander AG, Hertel P, Andersen HS, Eramo A, Loze JY, Potkin SG.
    Schizophr Res; 2015 Oct; 168(1-2):498-504. PubMed ID: 26232241
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.
    Correll CU, Skuban A, Ouyang J, Hobart M, Pfister S, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H.
    Am J Psychiatry; 2015 Sep 01; 172(9):870-80. PubMed ID: 25882325
    [Abstract] [Full Text] [Related]

  • 25. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG, Raoufinia A, Mallikaarjun S, Bricmont P, Peters-Strickland T, Kasper W, Baker RA, Eramo A, Sanchez R, McQuade R.
    Curr Med Res Opin; 2013 Oct 01; 29(10):1241-51. PubMed ID: 23822566
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ, Lane R, Nuamah I, Gopal S, Hough D.
    J Am Acad Child Adolesc Psychiatry; 2015 Feb 01; 54(2):126-137.e1. PubMed ID: 25617253
    [Abstract] [Full Text] [Related]

  • 27. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.
    Curr Med Res Opin; 2006 Nov 01; 22(11):2209-19. PubMed ID: 17076982
    [Abstract] [Full Text] [Related]

  • 28. Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes.
    Correll CU, Zhao J, Carson W, Marcus R, McQuade R, Forbes RA, Mankoski R.
    J Am Acad Child Adolesc Psychiatry; 2013 Jul 01; 52(7):689-698.e3. PubMed ID: 23800482
    [Abstract] [Full Text] [Related]

  • 29. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
    Streim JE, Porsteinsson AP, Breder CD, Swanink R, Marcus R, McQuade R, Carson WH.
    Am J Geriatr Psychiatry; 2008 Jul 01; 16(7):537-50. PubMed ID: 18591574
    [Abstract] [Full Text] [Related]

  • 30. Intramuscular aripiprazole in the control of agitation.
    Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May 01; 13(3):159-69. PubMed ID: 17522559
    [Abstract] [Full Text] [Related]

  • 31. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.
    Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG, Aripiprazole Study Group.
    J Clin Psychiatry; 2003 Sep 01; 64(9):1048-56. PubMed ID: 14628980
    [Abstract] [Full Text] [Related]

  • 32. Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study.
    Ryckmans V, Kahn JP, Modell S, Werner C, McQuade RD, Kerselaers W, Lissens J, Sanchez R.
    Pharmacopsychiatry; 2009 May 01; 42(3):114-21. PubMed ID: 19452380
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States.
    Citrome L, Kamat SA, Sapin C, Baker RA, Eramo A, Ortendahl J, Gutierrez B, Hansen K, Bentley TG.
    J Med Econ; 2014 Aug 01; 17(8):567-76. PubMed ID: 24758296
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.
    Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, Salzman PM, McQuade RD, Nyilas M, Carson WH.
    J Clin Psychiatry; 2017 Mar 01; 78(3):324-331. PubMed ID: 28146613
    [Abstract] [Full Text] [Related]

  • 35. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H, Rui Q, Ning X, Xu H, Gu N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):1002-8. PubMed ID: 21315787
    [Abstract] [Full Text] [Related]

  • 36. Initiation of aripiprazole once-monthly in patients with schizophrenia.
    Raoufinia A, Baker RA, Eramo A, Nylander AG, Landsberg W, Kostic D, Larsen F.
    Curr Med Res Opin; 2015 Mar 01; 31(3):583-92. PubMed ID: 25586294
    [Abstract] [Full Text] [Related]

  • 37. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
    Kane JM, Meltzer HY, Carson WH, McQuade RD, Marcus RN, Sanchez R, Aripiprazole Study Group.
    J Clin Psychiatry; 2007 Feb 01; 68(2):213-23. PubMed ID: 17335319
    [Abstract] [Full Text] [Related]

  • 38. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R.
    J Clin Psychopharmacol; 2008 Feb 01; 28(1):13-20. PubMed ID: 18204335
    [Abstract] [Full Text] [Related]

  • 39. Intramuscular aripiprazole in the acute management of psychomotor agitation.
    De Filippis S, Cuomo I, Lionetto L, Janiri D, Simmaco M, Caloro M, De Persis S, Piazzi G, Simonetti A, Telesforo CL, Sciarretta A, Caccia F, Gentile G, Kotzalidis GD, Girardi P.
    Pharmacotherapy; 2013 Jun 01; 33(6):603-14. PubMed ID: 23505124
    [Abstract] [Full Text] [Related]

  • 40. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH, Lin SH, Jang FL.
    J Clin Psychopharmacol; 2011 Oct 01; 31(5):563-8. PubMed ID: 21869699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.